Cargando…
Comparative treatment costs of risk‐stratified therapy for childhood acute lymphoblastic leukemia in India
BACKGROUND: To evaluate the treatment cost and cost effectiveness of a risk‐stratified therapy to treat pediatric acute lymphoblastic leukemia (ALL) in India. METHODS: The cost of total treatment duration was calculated for a retrospective cohort of ALL children treated at a tertiary care facility....
Autores principales: | Mungle, Tushar, Das, Nandana, Pal, Saikat, Gogoi, Manash Pratim, Das, Parag, Ghara, Niharendu, Ghosh, Debjani, Arora, Ramandeep Singh, Bhakta, Nickhill, Saha, Vaskar, Krishnan, Shekhar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939102/ https://www.ncbi.nlm.nih.gov/pubmed/36812120 http://dx.doi.org/10.1002/cam4.5140 |
Ejemplares similares
-
Protocol for ICiCLe-ALL-14 (InPOG-ALL-15-01): a prospective, risk stratified, randomised, multicentre, open label, controlled therapeutic trial for newly diagnosed childhood acute lymphoblastic leukaemia in India
por: Das, Nandana, et al.
Publicado: (2022) -
Unsatisfactory quality of E. coli asparaginase biogenerics in India: Implications for clinical outcomes in acute lymphoblastic leukaemia
por: Sidhu, Jasmeet, et al.
Publicado: (2021) -
Spectrum of respiratory viral infections in children with cancers: Experience from a tertiary cancer centre in Eastern India
por: Bhattacharyya, Arpita, et al.
Publicado: (2016) -
Characteristics and outcomes of gallbladder cancer patients at the Tata Medical Center, Kolkata 2017–2019
por: Dutta, Anindita, et al.
Publicado: (2023) -
Evaluating blinatumomab implementation in low- and middle-income countries: a study protocol
por: Duffy, Caitlyn, et al.
Publicado: (2022)